Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peripheral nociceptive nerve fibers, commonly known as nociceptors, are specialized high-threshold sensory neurons responsible for detecting and transmitting signals of potential or actual tissue damage to the central nervous system (StatPearls, 2023). These fibers are primarily categorized into two types: thinly myelinated A-delta fibers, which mediate rapid, sharp pain, and unmyelinated C-fibers, which convey slower, dull, or aching pain (NIH, 2001). They express a variety of specialized proteins, including voltage-gated sodium channels (Nav1.7, Nav1.8) and transient receptor potential (TRP) channels, which convert mechanical, thermal, or chemical stimuli into electrical impulses (PubMed, 2013). In pathological states, these fibers can become sensitized through inflammatory mediators, leading to chronic pain conditions such as neuropathy or hyperalgesia (Nature Reviews Neuroscience, 2014). Pharmacological interventions often target these fibers by blocking ion conductance or desensitizing receptors to interrupt the pain signaling pathway (StatPearls, 2023). For instance, local anesthetics like lidocaine inhibit sodium channels to prevent signal propagation, while topical capsaicin desensitizes TRPV1 receptors (DrugBank, 2024).
Drugs targeting these fibers act by inhibiting voltage-gated sodium channels (e.g., Nav1.7, Nav1.8) to block action potential propagation, modulating voltage-gated calcium channels (alpha2-delta subunit) to reduce excitatory neurotransmitter release, or activating and subsequently desensitizing TRPV1 channels to exhaust the fiber's signaling capacity (StatPearls, 2023; PubMed, 2013).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral nociceptive nerve fiber.